CVS二季度业绩超预期并上调指引，保险业务持续改善
CVS blows past estimates, hikes guidance as insurance unit continues to improve
推荐理由
CVS业绩超预期并上调指引，保险业务改善，对美股医疗板块投资者有参考价值，建议关注后续财报细节及合作进展。
CVS also announced a new collaboration with Eli Lilly that will make Zepbound and Foundayo accessible to eligible patients on the CVS Health app.
更进一步：量化金融体系
看懂新闻只是起点——沿量化金融路径，把它变成能交付的工程能力